A novel synthesis of 3-substituted imidazolidin-2-one-1-carbonyl chlorides

Full text of DOI:10.1080/00304940009356767

This article was downloaded by: [VUL Vanderbilt University]
On: 17 May 2013, At: 05:00
Publisher: Taylor & Francis
Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered
office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK
Organic Preparations and Procedures
International: The New Journal for
Organic Synthesis
Publication details, including instructions for authors and
subscription information:
http://www.tandfonline.com/loi/uopp20
A NOVEL SYNTHESIS OF 3-SUBSTITUTED
MDAZOLIDIN-2-ONE-1-CARBONYL
CHLORIDES
Weike Su a , Kewei Huang a b & Yongmin Zhang c
a Department of Pharmaceutical Engineering, Zhejiang University of
Technology, Hangzhou, 310014, PR China
b Department of Science and Technology, Zhejiang University of
Radio and Television, Hangzhou, 310012, PR China
c Department of Chemistry, Zhejiang University, Campus Xixi,
Hangzhou, 310028, PR China
Published online: 18 Feb 2009.
To cite this article: Weike Su , Kewei Huang & Yongmin Zhang (2000): A NOVEL SYNTHESIS OF 3-
SUBSTITUTED MDAZOLIDIN-2-ONE-1-CARBONYL CHLORIDES, Organic Preparations and Procedures
International: The New Journal for Organic Synthesis, 32:5, 498-501
To link to this article: http://dx.doi.org/10.1080/00304940009356767
PLEASE SCROLL DOWN FOR ARTICLE
Full terms and conditions of use: http://www.tandfonline.com/page/terms-and-conditions
This article may be used for research, teaching, and private study purposes. Any
substantial or systematic reproduction, redistribution, reselling, loan, sub-licensing,
systematic supply, or distribution in any form to anyone is expressly forbidden.
The publisher does not give any warranty express or implied or make any representation
that the contents will be complete or accurate or up to date. The accuracy of any
instructions, formulae, and drug doses should be independently verified with primary
sources. The publisher shall not be liable for any loss, actions, claims, proceedings,
demand, or costs or damages whatsoever or howsoever caused arising directly or
indirectly in connection with or arising out of the use of this material.